Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2003
04/17/2003CA2464662A1 Modulation of the expression of genes dependent on stat-1
04/17/2003CA2463507A1 Methods for the synthesis of substituted purines
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
04/17/2003CA2462892A1 Human 3 relaxin
04/17/2003CA2462886A1 Flashmelt oral dosage formulation
04/17/2003CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003CA2462875A1 Allylamides useful in the treatment of alzheimer's disease
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2462861A1 Piperidine compounds as muscarinic antagonists
04/17/2003CA2462858A1 Low molecular weight gtpase rhot
04/17/2003CA2462806A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide
04/17/2003CA2462801A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2461961A1 Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
04/17/2003CA2461655A1 Nogo receptor-mediated blockade of axonal growth
04/17/2003CA2461369A1 Arylsulphonyl-substituted tetrahydro-and-hexahydro-carbazoles as 5-ht-6 receptor ligands
04/17/2003CA2461064A1 Inhibition of stat-1
04/17/2003CA2460625A1 Structural and cytoskeleton-associated proteins
04/17/2003CA2460480A1 Molecules for disease detection and treatment
04/17/2003CA2460476A1 Protein modification and maintenance molecules
04/17/2003CA2458645A1 Intracellular signaling molecules
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003CA2458388A1 Novel benzothiazine derivatives, their preparation and use
04/16/2003EP1302542A1 Novel physiologically active peptide and use thereof
04/16/2003EP1302536A2 Embryonic stem cells and neural progenitor cells derived therefrom
04/16/2003EP1302534A1 Cell fraction containing cells capable of differentiating into neural cells
04/16/2003EP1302533A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof
04/16/2003EP1302464A1 Process for preparation of 10-methoxycarbamazepine
04/16/2003EP1302201A1 Pharmaceutical composition improved in peroral absorbability
04/16/2003EP1301604A2 Substrates and assays for beta-secretase activity
04/16/2003EP1301598A2 Cell cycle proteins and mitosis-associated molecules
04/16/2003EP1301595A2 G-protein coupled receptors
04/16/2003EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
04/16/2003EP1301535A2 G-protein coupled receptors
04/16/2003EP1301531A2 Reagents and methods for identification of binding agents
04/16/2003EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies
04/16/2003EP1301522A1 Novel compounds and methods
04/16/2003EP1301517A1 Thienopyrrolidinones
04/16/2003EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
04/16/2003EP1301511A2 IMIDAZO 1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
04/16/2003EP1301508A1 Novel processes for the preparation of 4-phenylpiperidine derivatives
04/16/2003EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
04/16/2003EP1301506A1 Cyclic amino acid derivatives
04/16/2003EP1301503A1 Coumarin derivatives with comt inhibiting activity
04/16/2003EP1301502A1 Novel compounds and their use as glycine transport inhibitors
04/16/2003EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
04/16/2003EP1301495A2 Inhibitors of copper-containing amine oxidases
04/16/2003EP1301490A2 5-substituted 2-aryl-4-pyrimidinones
04/16/2003EP1301484A2 Capsaicin receptor ligands
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1301476A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation
04/16/2003EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
04/16/2003EP1301463A1 Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
04/16/2003EP1301214A2 Methods of transducing neural cells using lentivirus vectors
04/16/2003EP1301210A2 Compositions containing therapeutically active components having enhanced solubility
04/16/2003EP1301206A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
04/16/2003EP1301199A2 Methods for therapy of neurodegenerative disease of the brain
04/16/2003EP1301181A2 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
04/16/2003EP1301173A1 A medicinal aerosol formulation
04/16/2003EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/16/2003EP1173431B1 Method for the preparation of citalopram
04/16/2003EP1102769B1 Tricyclic carboxamides
04/16/2003EP1100472B1 Pharmaceutical compositions comprising ibuprofen and domperidone
04/16/2003EP1086682B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
04/16/2003EP1075478B1 Phenylurea and phenylthio urea derivatives
04/16/2003EP1028718B1 Extended release formulation containing venlafaxin
04/16/2003EP1007505B1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
04/16/2003EP0994864B1 Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
04/16/2003EP0970083B1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION
04/16/2003EP0951465B1 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof
04/16/2003EP0918455B1 Use of galanin to repair nerve damage
04/16/2003EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
04/16/2003EP0787724B1 Novel intermediate for production and process for producing pyridine derivative
04/16/2003EP0769958B1 Inhibitors of leukocyte adhesion
04/16/2003EP0765160B1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
04/16/2003EP0649414B1 Opioid diarylmethylpiperazines and piperidines
04/16/2003CN1411556A Synergistic activation of regulatory elements by Rel proteins and steroid receptor
04/16/2003CN1411459A Compound and method for treatment of pain
04/16/2003CN1411458A Saccharin derivatives as orally active elastase inhibitors
04/16/2003CN1411456A Chemokine receptor binding heterocyclic compounds
04/16/2003CN1411454A Method for preparation of citalopram
04/16/2003CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses
04/16/2003CN1411448A Pyrazole derivatives which modulate human 5-serotonin receptors
04/16/2003CN1411447A Polymorphic crystalline forms of celecoxib
04/16/2003CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
04/16/2003CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/16/2003CN1411375A Use of bioactive metabolites of gepirone for treatment of psychological disorders
04/16/2003CN1411374A Substituted piperazine and piperidine calcium channel blockers
04/16/2003CN1411367A Suspension comprising oxcarbazepine
04/16/2003CN1410118A Chinese patent medicine for suppressing pain without habituation and its preparation method
04/16/2003CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent
04/16/2003CN1105723C Spirocyclic metalloprotease inhibitors
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/16/2003CN1105576C Insulin analog formulation
1 ... 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 ... 1833